The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world effectiveness and safety of camrelizumab-based neoadjuvant therapy in resectable esophageal cancer: Initial results of a prospective multicenter observational study.
 
Yi Zhang
No Relationships to Disclose
 
Guoyi Shen
No Relationships to Disclose
 
Rongyu Xu
No Relationships to Disclose
 
Guozhong Huang
No Relationships to Disclose
 
Shengsheng Yang
No Relationships to Disclose
 
Qingfeng Zheng
No Relationships to Disclose
 
Zhijun Huang
No Relationships to Disclose
 
Hongbing Duan
No Relationships to Disclose
 
Liangyun Ma
No Relationships to Disclose
 
Libao Yang
No Relationships to Disclose
 
Yunfeng Yi
No Relationships to Disclose
 
Rongxing Liu
No Relationships to Disclose
 
Kezhi Li
No Relationships to Disclose
 
Shaogeng Chen
No Relationships to Disclose